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Purpose: Immune reconstitution uveitis (IRU) is a well-described phenomenon that by deﬁnition occurs
in patients with AIDS who undergo highly active antiretroviral therapy resulting in a rebound inﬂam-
matory response to the presence of clinically latent cytomegalovirus (CMV). We hypothesize that similar
phenomena may exist in other cohorts who undergo transient immunosuppression with rapid white
blood cell count recovery.
Observations: A patient developed rebound inﬂammation a few months after cataract surgery with
intraocular lens placement characterized by photophobia, signiﬁcant anterior chamber cell and ﬁbrinous
deposits. She had a history of multiple myeloma treated with chemotherapy and a recovery of white
blood cell counts following autologous bone marrow transplant. She underwent a thorough work-up for
infectious etiologies, as well as the presence of intraocular CMV, which were negative. Her vision and
symptoms improved to baseline with the use of topical steroids and at one year her exam remained
stable.
Conclusions and Importance: With a negative work-up for infectious etiologies, and the timing and
clinical presentation, the patient's inﬂammation was likely the result of rapid white blood cell count
recovery following iatrogenic immunosuppression similar to the mechanism described for IRU.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Immune system reconstitution following either infectious,
neoplastic, or iatrogenic immunosuppression is associated with a
systemic process known as immune reconstitution inﬂammatory
syndrome. In this process, there is a paradoxical worsening of in-
ﬂammatory signs and symptoms associated with a pre-existent
infection acquired during the period of immunosuppression.
Within the realm of ophthalmology, immune reconstitution uveitis
(IRU) is a well-described phenomenon that by deﬁnition occurs in
patients with AIDS placed on highly active antiretroviral therapy
which results in a rebound inﬂammatory response to the presence
of clinically latent cytomegalovirus (CMV). We hypothesize that
similar phenomena may exist in other cohorts who undergo tran-
sient immunosuppression with rapid white blood cell count
recovery.S.C. Kavoussi), Kyle.kovacs@
lasil), Patrick.coady@yale.edu
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A 65-year-old woman with a history of multiple myeloma and
diabetes without retinopathy was seen in consultation by the retina
service for a week of worsening bilateral light sensitivity and pro-
gressive decrease in vision despite being re-started on topical ste-
roids. She had uncomplicated bilateral cataract surgery a few
months earlier (92 days prior in the right eye and 71 days prior in
the left eye). Her last post-operative cataract check showed no signs
of intraocular inﬂammation. Seventeen days before presentation,
she had received an autologous bone marrow transplant in the
setting of melphalan chemotherapy for multiple myeloma. Her
worsening symptoms correlated with a rebound in her blood
counts (Fig. 1).
Best-corrected visual acuity (BCVA) was 20/200 in the right eye
and 20/60 in the left eye. Intraocular pressures were unremarkable.
There was bilateral mild conjunctival injection, corneas were clear
without keratic precipitates, and anterior chambers were notable
for 4 þ cell in the right eye and 2 þ cell in the left eye. Posterior
synechiae were present in the right eye and a ﬂat, dense, pale-gray,
ﬁbrotic membrane with an irregular texture covered the anteriornder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Timing and severity of patient's immune reconstitution uveitis correlated with rebound in serum WBC (white blood cell) count, ANC (absolute neutrophil count) and ALC
(absolute lymphocyte count). CE/IOL (Cataract extraction, placement of intraocular lens); HSCT (hematopoietic stem cell transplant).
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(IOL). The left one-piece acrylic IOL had numerous pale ﬁbrotic
deposits on the anterior surface. Dilated fundus exam was normal
in both eyes with a hazy view, and B-scan ultrasonography was
notable for mild anterior vitritis in the right eye.
The differential diagnosis included late infectious endoph-
thalmitis, non-infectious bilateral anterior uveitis, rebound
inﬂammation after cataract surgery, immune reconstitution uveitis
following autologous stem cell rescue, and ocular involvement of
multiple myeloma. Anterior chamber paracentesis and vitreous tap
and injection of intravitreal antibiotics were performed for the
right eye. Work up for infectious, uveitic, and malignant causes
were unremarkable (Table 1). The patient's medications at the time
of admission included: ciproﬂoxacin, ﬂuconazole, hydrocodone-
acetaminophen, lorazepam, losartan, ondansetron, oxybutynin,
prochlorperazine, sitagliptin-metformin, zoledronic acid injections
three weeks prior, and valacyclovir.
The patient's topical prednisolone acetate was increased to
every 2 h and later increased again to every hour. Eight days afterTable 1
Uveitis and infection work-up performed was negative.
Specimen (timepoint) Test
Vitreous Tap OD (Day 92) Gram Stain
Bacterial and fungal culture
Cytology e Inﬂammatory cells
Serum (Day 92) Toxoplasma gondii Ab IgG
Toxoplasma gondii Ab IgM
Toxoplasma gondii PCR
Quantiferon gold
VDRL
ANA
ANCA screen
HLA B27
Angiotensin converting enzyme
Aqueous Tap OD (Day 94) VZV PCR
HSV PCR
EBV PCR
CMV PCR
Adenovirus PCR
Serum (Day 94) Blood Cultureincreased topical steroid treatment, BCVA improved to 20/30 OD
and 20/25 OSwith reduction in anterior chamber cell to 2þ OD and
1 þ OS and persistent ﬁbrinous deposits on the IOLs (Fig. 2). Sys-
temic steroids were not used due to diabetes control and the pa-
tient deferred local steroid injections. By 1.5 months, BCVA was
stable and all anterior chamber cell had resolved. At 2 months, all
steroids had been discontinued. By 3 months, all ﬁbrin membranes
resolved, with mild residual posterior synechiae. At 6 months and
again at 1 year, her exam remained stable.
3. Discussion
With negative ocular and systemic work-up, an immune
reconstitution phenomenon is the proposed mechanism of her
bilateral anterior uveitis one week following autologous stem cell
rescue and recent bilateral cataract extraction. A similar entity,
immune reconstitution uveitis (IRU), was ﬁrst described as a newFig. 2. Day 100; anterior segment photo of the right eye shows residual ﬁbrin mem-
brane, posterior synechiae. 2 þ cell, vision improved to 20/30.
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with inactive CMV retinitis: HAART initiation results in CD4þ T-
lymphocyte activation and subsequent intraocular inﬂammation
[1]. Cytokine proﬁles clearly distinguish the inﬂammation of IRU
from that associated with active CMV retinitis [2]. While still a
matter of investigation, the primary mechanism of IRU likely in-
volves either primary CMV fragments or a CMV-speciﬁc antigen
delivered to lymphoid tissue, triggering a T-cell response [1].) IRU is
typically a posterior entity, but anterior segment involvement has
been shown to follow the recent introduction of foreign material
(intraocular surgery or injection) [3].
Besides IRU and the listed work-up, a number of other etiol-
ogies deserve speciﬁc mention. Though this patient was not HIV
positive and CMV was not identiﬁed in her ocular samples, she did
have positive CMV serology prior to transplant however this in
and of itself is common and CMV re-activation following autolo-
gous transplant is exceedingly rare. Similarly, HSV serology is not
routinely sent prior to bone marrow transplant, but prophylactic
treatment with valacyclovir (as this patient underwent) is thought
to generally eliminate HSV as a causative pathogen during the
short period of immunosuppression following transplant. There
are a few alternative etiologies in immunocompromised patients
which were not tested during the patient's initial work-up,
including HHV-6 and torque teno virus. Valacyclovir is typically
effective in preventing HHV-6 reactivation (though not as treat-
ment for a primary infection), and our patient was already being
treated prophylactically prior to onset of her symptoms [4]. Torque
teno virus has been shown to be related to culture negative
endophthalmitis (though unclear if as a causative pathogen), but
though not tested speciﬁcally in our patient the lack of posterior
segment involvement and would make this less likely to be a
primary etiology in our patient [5]. Multiple myeloma can often
masquerade as refractory anterior uveitis if there is invasion of the
iris, however the patient's cytology from her vitreous and aqueous
taps were negative and the inﬂammation would have been un-
likely to respond to steroid therapy. There were no signs of pos-
terior segment inﬂammation or any evidence of occult diabetic
retinopathy on examination (patient's last hemoglobin A1c 7.8%),
which could have exacerbated post-operative inﬂammation.
Finally, the patient was on no medications that are known to cause
intraocular inﬂammation.4. Conclusions
With a negative work-up for infectious etiologies, and the
timing and clinical presentation, the patient's inﬂammation is
believed to be the result of rapid white blood cell count recovery
following iatrogenic immunosuppression similar to the mechanism
described for IRU.
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